调控性T细胞定义了CD8+T细胞瘤透的亲和度值
Mona O Mohsen1,2,3, Romano Josi4,5,6, Sanjana V Marar5
1Department of Rheumatology and Immunology, Inselspital, University of Bern, Bern, Switzerland. mona.mohsen@unibe.ch.
NPJ vaccines
|June 13, 2025
概括
削减调节性T细胞 (Tregs) 提高了低亲和性T细胞对瘤的有效性. 这种Treg消耗策略可以增强抗瘤免疫反应,并在临床前模型中提高生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 瘤特异性T细胞受体 (TCR) 库中往往缺乏高亲和度的TCR.
- 调节性T细胞 (Tregs) 抑制抗瘤免疫反应,进一步限制疗效.
- 开发有效的针对低亲和性T细胞的癌症疫苗仍然是一个挑战.
研究的目的:
- 调查Treg耗尽是否可以增强低亲和性T细胞的抗瘤疗效.
- 为了评估一个疫苗接种策略,将一个弱激动性疫苗与Treg耗尽结合起来.
- 评估对T细胞透,功能和瘤进展的影响.
主要方法:
- 作为模型抗原,利用从LCMV糖蛋白p33中获得的弱激动性 (A4Y) 作为模型抗原.
- 使用病毒样颗粒 (VLP) 作为疫苗平台.
- 在B16F10黑色素瘤模型中测试了这种方法,将A4Y-VLP疫苗与Treg耗尽相结合.
主要成果:
- 在A4Y和p33之间观察到有限的体内激光交叉反应性.
- 单独使用A4Y-VLP疫苗并没有抑制瘤的进展.
- 将A4Y-VLP疫苗与Treg枯竭结合,诱导了强大的CD8+T细胞透,增强了T细胞功能,并改善了无瘤生存率.
- 在一个单独的低亲缘关系疫苗模型中,Treg消耗也增强了抗瘤反应.
结论:
- 在抗瘤免疫中,Treg耗尽可以克服低亲和性T细胞的局限性.
- 这一策略有望提高针对瘤相关抗原 (TAA) 的疫苗的疗效.
- 将Treg消耗与低亲和度疫苗接种相结合,代表了癌症免疫疗法的潜在进展.
相关概念视频
T Cell Activation and Clonal Selection
692
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
692
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


